Literature DB >> 16972

Enhancement of murine cytomegalovirus infection during graft-vs.-host reaction.

J N Dowling, B C Wu, J A Armstrong, M Ho.   

Abstract

A mouse model was used for elucidation of the role of a graft-vs-host reaction in promoting cytomegalovirus infection. F1 (DBA/2 X C3H/He) hybrid mice were infected with murine cytomegalovirus. Five weeks later, a graft-vs.-host reaction was produced in the chronically infected animals by the administration of multiple doses of DBA/2 parental splenocytes. Cytomegalovirus was recovered more often from the organs of mice undergoing graft-vs.-host reaction than from those of control animals (P less than 0.001). These results indicate that the graft-vs.-host reaction alone can enhance murine cytomegalovirus infection in a chronically infected host and may help explain the high incidence of cytomegalovirus infection after bone marrow allograft transplantation in man.

Entities:  

Mesh:

Year:  1977        PMID: 16972     DOI: 10.1093/infdis/135.6.990

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Virus infections after transplantation in man. Brief review.

Authors:  M Ho
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

2.  Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency.

Authors:  M Hummel; Z Zhang; S Yan; I DePlaen; P Golia; T Varghese; G Thomas; M I Abecassis
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period.

Authors:  S A Walker; T R Rogers; P G Riches; S White; J R Hobbs
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

4.  Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus.

Authors:  M Ho
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

5.  Cytomegalovirus-specific lymphocyte transformations in subjects of different ages with primary immunodeficiency.

Authors:  T Tamura; S Chiba; W Abo; Y Chiba; T Nakao
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

6.  Prevention and treatment of cytomegalovirus infections with interferons and immune globulins.

Authors:  J D Meyers
Journal:  Infection       Date:  1985       Impact factor: 3.553

7.  Prevention and treatment of cytomegalovirus infections with interferons and immune globulins.

Authors:  J D Meyers
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.